{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:22:46Z","timestamp":1791285766327,"version":"4.1.0"},"reference-count":120,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.semnephrol.2012.06.010","type":"journal-article","created":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T05:00:59Z","timestamp":1346821259000},"page":"385-393","source":"Crossref","is-referenced-by-count":136,"title":["VEGF and Podocytes in Diabetic Nephropathy"],"prefix":"10.1016","volume":"32","author":[{"given":"Alda","family":"Tufro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delma","family":"Veron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2012.06.010_bib1","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.2479986","article-title":"Vascular endothelial growth factor is a secreted angiogenic mitogen","volume":"246","author":"Leung","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib2","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.2479987","article-title":"Vascular permeability factor, an endothelial cell mitogen related to PDGF","volume":"246","author":"Keck","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1091\/mbc.E09-07-0591","article-title":"Vascular endothelial growth factor: much more than an angiogenesis factor","volume":"21","author":"Senger","year":"2010","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib4","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nature04479","article-title":"Endothelial cells and VEGF in vascular development","volume":"438","author":"Coultas","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/380439a0","article-title":"Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene","volume":"380","author":"Ferrara","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/376062a0","article-title":"Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice","volume":"376","author":"Shalaby","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/376066a0","article-title":"Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium","volume":"376","author":"Fong","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/nature03987","article-title":"Pathophysiological consequences of VEGF-induced vascular permeability","volume":"437","author":"Weis","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib10","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s00125-005-1937-6","article-title":"Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients","volume":"48","author":"Rossing","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib11","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1523-1755.2004.00870.x","article-title":"Improved survival in patients obtaining remission of nephrotic range albuminuria in diabetic nephropathy","volume":"66","author":"Hovind","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib12","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.2337\/diacare.26.4.1258","article-title":"Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes","volume":"26","author":"Hovind","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jdiacomp.2006.05.005","article-title":"Association of VEGF-1499C\u2192T polymorphism with diabetic nephropathy in type 1 diabetes mellitus","volume":"21","author":"McKnight","year":"2007","journal-title":"J Diab Compl"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib14","doi-asserted-by":"crossref","first-page":"F240","DOI":"10.1152\/ajprenal.1995.268.2.F240","article-title":"Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney","volume":"268","author":"Simon","year":"1995","journal-title":"Am J Physiol Renal Fluid Electrolyte Physiol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib15","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1681\/ASN.V10102125","article-title":"Vascular endothelial growth factor induces nephrogenesis, and vasculogenesis","volume":"10","author":"Tufro","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib16","doi-asserted-by":"crossref","first-page":"F422","DOI":"10.1152\/ajprenal.00448.2005","article-title":"Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP","volume":"291","author":"Guan","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib17","doi-asserted-by":"crossref","first-page":"F767","DOI":"10.1152\/ajprenal.00337.2003","article-title":"Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein","volume":"286","author":"Cui","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1523-1755.2005.67101.x","article-title":"Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells","volume":"67","author":"Villegas","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib19","doi-asserted-by":"crossref","first-page":"F905","DOI":"10.1152\/ajprenal.2000.278.6.F905","article-title":"Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells","volume":"278","author":"Kanellis","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib20","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1097\/01.ASN.0000024436.00520.D8","article-title":"VEGF expression in hypoxia and hyperglycemia: reciprocal effect on branching angiogenesis in epithelial-endothelial co-cultures","volume":"8","author":"Kim","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib21","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1006\/dbio.2000.9845","article-title":"VEGF spatially directs angiogenesis during metanephric development in vitro","volume":"227","author":"Tufro","year":"2000","journal-title":"Dev Biol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1172\/JCI17423","article-title":"Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases","volume":"111","author":"Eremina","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib23","first-page":"765","article-title":"Neovasculature induced by vascular endothelial growth factor is fenestrated","volume":"757","author":"Roberts","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib24","first-page":"H560","article-title":"VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature","volume":"290","author":"Kamba","year":"2006","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib25","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1681\/ASN.2005080810","article-title":"Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival","volume":"17","author":"Eremina","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib26","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ki.2010.64","article-title":"Induction of podocyte VEGF-A overexpression in adult mice causes glomerular disease","volume":"77","author":"Veron","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib27","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.2353\/ajpath.2010.091146","article-title":"Induction of podocyte VEGF164 overexpression at different stages of development causes congenital nephrosis or steroid resistant nephrotic syndrome","volume":"177","author":"Veron","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib28","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.2010010010","article-title":"Pathologic classification of diabetic nephropathy","volume":"21","author":"Tervaert","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib29","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib30","doi-asserted-by":"crossref","first-page":"e40589","DOI":"10.1371\/journal.pone.0040589","article-title":"Acute podocyte VEGF-A knockdown disrupts \u03b1V\u03b23 integrin signaling in the glomerulus","volume":"7","author":"Veron","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib31","doi-asserted-by":"crossref","first-page":"F48","DOI":"10.1152\/ajprenal.00146.2004","article-title":"Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes","volume":"288","author":"Foster","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib32","doi-asserted-by":"crossref","first-page":"F1656","DOI":"10.1152\/ajprenal.00275.2009","article-title":"The balance of autocrine VEGF-A and VEGF-C determines podocyte survival","volume":"297","author":"M\u00fcller-Deile","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib33","doi-asserted-by":"crossref","first-page":"30336","DOI":"10.1074\/jbc.273.46.30336","article-title":"Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase\/Akt signal transduction pathway","volume":"273","author":"Gerber","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib34","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cell.2007.06.054","article-title":"Autocrine VEGF signaling is required for vascular homeostasis","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib35","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.2337\/db08-0647","article-title":"Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice","volume":"57","author":"Ku","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib36","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1128\/MCB.23.14.4917-4928.2003","article-title":"Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling","volume":"23","author":"Huber","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib37","doi-asserted-by":"crossref","first-page":"39933","DOI":"10.1074\/jbc.M111.241620","article-title":"Vascular endothelial growth factor receptor 2 direct interaction with nephrin links VEGF-A signals to actin in kidney podocytes","volume":"286","author":"Bertuccio","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib38","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1681\/ASN.2010030295","article-title":"Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling","volume":"21","author":"Sison","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib39","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1534\/genetics.110.121608","article-title":"When Cre-mediates recombination does not result in protein loss","volume":"186","author":"Turlo","year":"2010","journal-title":"Genetics"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib40","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00125-010-2034-z","article-title":"Podocyte vascular endothelial growth factor (Vegf164) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes","volume":"54","author":"Veron","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib41","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.tcb.2007.06.006","article-title":"Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton","volume":"17","author":"Faul","year":"2007","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib42","doi-asserted-by":"crossref","first-page":"F959","DOI":"10.1152\/ajprenal.00559.2007","article-title":"The molecular and functional phenotype of glomerular podocytes reveals key features of contractile smooth muscle cells","volume":"295","author":"Saleem","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib43","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa1101273","article-title":"MYO1E mutations and childhood familial focal segmental glomerulosclerosis","volume":"365","author":"Mele","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib44","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1365-2443.2009.01343.x","article-title":"Different roles of Foxo1 and Foxo3 in the control of endothelial cell morphology","volume":"14","author":"Matsukawa","year":"2009","journal-title":"Genes Cells"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib45","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.devcel.2009.08.011","article-title":"The molecular basis of vascular lumen formation in the developing mouse aorta","volume":"17","author":"Strili\u0107","year":"2009","journal-title":"Dev Cell"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fasebj.13.1.9","article-title":"Vascular endothelial growth factor (VEGF) and its receptors","volume":"13","author":"Neufeld","year":"1999","journal-title":"FASEB J"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib47","doi-asserted-by":"crossref","first-page":"26988","DOI":"10.1016\/S0021-9258(18)47116-5","article-title":"Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor","volume":"269","author":"Waltenberger","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib48","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/emboj\/20.11.2768","article-title":"A single autophosphorylation site on KDR\/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells","volume":"20","author":"Takahashi","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib49","doi-asserted-by":"crossref","first-page":"12959","DOI":"10.1074\/jbc.M110.204024","article-title":"PKC alpha mediates beta-arrestin2-dependent nephrin endocytosis in hyperglycemia","volume":"286","author":"Quack","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib50","doi-asserted-by":"crossref","first-page":"e10185","DOI":"10.1371\/journal.pone.0010185","article-title":"Podocytic PKC-alpha is regulated in murine and human diabetes and mediates nephrin endocytosis","volume":"5","author":"Tossidou","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib51","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/ATVBAHA.108.162842","article-title":"Differential regulation of VEGF signaling by PKC-alpha and PKC-epsilon in endothelial cells","volume":"28","author":"Rask-Madsen","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib52","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1046\/j.1523-1755.2000.07504.x","article-title":"Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy","volume":"75","author":"Hovind","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib53","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1046\/j.1464-5491.2000.00350.x","article-title":"Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with type 1 diabetes mellitus: relation to glycaemic control and microvascular complications","volume":"17","author":"Chiarelli","year":"2000","journal-title":"Diabet Med"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/dmrr.1164","article-title":"The role of metabolic and haemodynamic factors in podocyte injury in diabetes","volume":"27","author":"Stieger","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib55","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1681\/ASN.V75661","article-title":"Expression of vascular permeability factor (VPF\/VEGF) is altered in many glomerular diseases","volume":"7","author":"Shulman","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib56","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/sj.ki.5000294","article-title":"Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man","volume":"69","author":"Hohenstein","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib57","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1681\/ASN.2009070721","article-title":"Animal models of diabetic complications consortium","volume":"20","author":"Brosius","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib58","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1586\/eem.09.70","article-title":"Abnormalities in signaling pathways in diabetic nephropathy","volume":"5","author":"Brosius","year":"2010","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib59","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1464-5491.2004.01200.x","article-title":"Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in type 2 diabetes mellitus","volume":"21","author":"Kim","year":"2004","journal-title":"Diabet Med"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib60","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2337\/diabetes.48.11.2229","article-title":"Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes","volume":"48","author":"Cooper","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib61","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.semnephrol.2007.01.009","article-title":"The renin-angiotensin system and diabetic nephropathy","volume":"27","author":"Gurley","year":"2007","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib62","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000101797","article-title":"Cellular and molecular mechanisms of proteinuria in diabetic nephropathy","volume":"106","author":"Wolf","year":"2007","journal-title":"Nephron Physiol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib63","doi-asserted-by":"crossref","first-page":"10190","DOI":"10.1073\/pnas.1005144107","article-title":"Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice","volume":"107","author":"Kakoki","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib64","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/cvr\/cvn170","article-title":"B2-kinin receptor plays a key role in B1-, angiotensin converting enzyme inhibitor-, and vascular endothelial growth factor-stimulated in vitro angiogenesis in the hypoxic mouse heart","volume":"80","author":"Sanchez de Miguel","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib65","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1074\/jbc.M109493200","article-title":"Rapid transactivation of the vascular endothelial growth factor receptor KDR\/Flk-1 by the bradykinin B2 receptor contributes to endothelial nitric-oxide synthase activation in cardiac capillary endothelial cells","volume":"277","author":"Thuringer","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib66","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI114844","article-title":"An insertion\/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels","volume":"86","author":"Rigat","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib67","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ki.2009.208","article-title":"Kallikrein protects against microalbuminuria in experimental type I diabetes","volume":"76","author":"Bodin","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib68","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.2337\/db07-1212","article-title":"ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes","volume":"57","author":"Tikellis","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib69","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2119\/molmed.2010.00111","article-title":"Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition","volume":"17","author":"Liu","year":"2011","journal-title":"Mol Med"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib70","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1152\/physrev.00018.2001","article-title":"Free radicals in the physiological control of cell function","volume":"82","author":"Dr\u00f6ge","year":"2002","journal-title":"Physiol Rev"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib71","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1475-2840-4-5","article-title":"Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice","volume":"4","author":"Johansen","year":"2005","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib72","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2337\/db09-0663","article-title":"Modulation of notch-1 signaling alleviates vascular endothelial growth factor-mediated diabetic nephropathy","volume":"59","author":"Lin","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib73","doi-asserted-by":"crossref","first-page":"26765","DOI":"10.1016\/S0021-9258(19)61441-9","article-title":"Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells","volume":"275","author":"Richard","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib74","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1172\/JCI119868","article-title":"Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells","volume":"100","author":"Papapetropoulos","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib75","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nm0897-879","article-title":"Reciprocal relation between VEGF and NO in the regulation of endothelial integrity","volume":"3","author":"Tsurumi","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib76","doi-asserted-by":"crossref","first-page":"31963","DOI":"10.1074\/jbc.M200082200","article-title":"Vanadate-induced expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase\/Akt pathway and reactive oxygen species","volume":"277","author":"Gao","year":"2002","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"10.1016\/j.semnephrol.2012.06.010_bib77","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.diabres.2008.09.030","article-title":"Uncoupling of VEGF with NO as a mechanism for diabetic nephropathy","volume":"82","author":"Nakagawa","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"issue":"Suppl 2","key":"10.1016\/j.semnephrol.2012.06.010_bib78","doi-asserted-by":"crossref","first-page":"S291","DOI":"10.2337\/dc11-s241","article-title":"Endothelial factors and diabetic nephropathy","volume":"34","author":"Karalliedde","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib79","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2337\/db09-0119","article-title":"Abnormal angiogenesis in diabetic nephropathy","volume":"58","author":"Nakagawa","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib80","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1681\/ASN.2006050459","article-title":"Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy","volume":"18","author":"Nakagawa","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib81","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1681\/ASN.2006070798","article-title":"Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice","volume":"17","author":"Zhao","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib82","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.1018766108","article-title":"A modest decrease in endothelial NOS in mice comparable to that associated with human NOS3 variants exacerbates diabetic nephropathy","volume":"108","author":"Wang","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib83","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jdiacomp.2007.11.011","article-title":"Association of endothelial nitric oxide synthase Glu298Asp, 4b\/a, and -786T>C gene variants with diabetic nephropathy","volume":"22","author":"Ezzidi","year":"2008","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib84","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2353\/ajpath.2007.060610","article-title":"Lack of endothelial nitric-oxide synthase leads to progressive focal renal injury","volume":"170","author":"Forbes","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib85","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.semnephrol.2007.01.006","article-title":"AGE, RAGE, and ROS in diabetic nephropathy","volume":"27","author":"Tan","year":"2007","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib86","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s001250051198","article-title":"Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195","volume":"42","author":"Tsuchida","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib87","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0002-9440(10)63909-0","article-title":"RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy","volume":"162","author":"Wendt","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib88","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1681\/ASN.V1191656","article-title":"Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease","volume":"11","author":"Tanji","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib89","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s00109-005-0688-7","article-title":"Understanding RAGE, the receptor for advanced glycation end products","volume":"83","author":"Bierhaus","year":"2005","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib90","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2337\/db07-1119","article-title":"Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway","volume":"57","author":"Thallas-Bonke","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib91","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.2337\/db06-0221","article-title":"RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin","volume":"55","author":"Myint","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib92","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/s00125-011-2045-4","article-title":"Genetic deficiency of aldose reductase counteracts the development of diabetic nephropathy in C57BL\/6 mice","volume":"54","author":"Liu","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib93","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semnephrol.2007.01.012","article-title":"Histopathology of diabetic nephropathy","volume":"27","author":"Fioretto","year":"2007","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib94","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.devcel.2009.05.010","article-title":"Essential role of TGF-beta signaling in glucose-induced cell hypertrophy","volume":"17","author":"Wu","year":"2009","journal-title":"Dev Cell"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib95","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1681\/ASN.V125993","article-title":"Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes","volume":"12","author":"de Vriese","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib96","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.2337\/diabetes.51.10.3090","article-title":"Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody","volume":"51","author":"Flyvbjerg","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib97","first-page":"405A","article-title":"VEGF-A dysregulation alters the glomerular phenotype of streptozotocin diabetic mice","volume":"19","author":"Veron","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib98","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/ncb1486","article-title":"VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin","volume":"8","author":"Gavard","year":"2006","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib99","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1007\/s00125-011-2270-x","article-title":"Deletion of platelet-derived growth factor receptor-\u03b2 improves diabetic nephropathy in Ca(2+)\/calmodulin-dependent protein kinase II\u03b1 (Thr286Asp) transgenic mice","volume":"54","author":"Suzuki","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1126\/science.277.5322.48","article-title":"Signaling vascular morphogenesis and maintenance","volume":"277","author":"Hanahan","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib101","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/sj.ki.5002726","article-title":"Semaphorin3a disrupts podocyte foot processes causing acute proteinuria","volume":"73","author":"Tapia","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib102","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1242\/dev.037267","article-title":"Semaphorin3a regulates endothelial cell number and podocyte differentiation during glomerular development","volume":"136","author":"Reidy","year":"2009","journal-title":"Development"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib103","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1172\/JCI46322","article-title":"Angiopoietin-1 is essential in mouse vasculature during development and in response to injury","volume":"121","author":"Jeansson","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib104","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1681\/ASN.2006010064","article-title":"Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice","volume":"17","author":"Sung","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib105","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2005020217","article-title":"Therapeutic potential of angiostatin in diabetic nephropathy","volume":"17","author":"Zhang","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib106","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2337\/diabetes.53.7.1831","article-title":"Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy","volume":"53","author":"Yamamoto","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib107","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.2337\/diabetes.54.10.2891","article-title":"Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model","volume":"54","author":"Ichinose","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib108","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/468042a","article-title":"Diabetes: podocytes lose their footing","volume":"468","author":"Rask-Madsen","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib109","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1681\/ASN.V1171236","article-title":"Vascular endothelial growth factor receptors in human mesangium in vitro and in glomerular disease","volume":"11","author":"Thomas","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib110","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1046\/j.1523-1755.2002.00528.x","article-title":"Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes","volume":"62","author":"Iglesias-de la Cruz","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib111","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10456-004-8272-2","article-title":"Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro","volume":"7","author":"Wang","year":"2004","journal-title":"Angiogenesis"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib112","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12576-010-0128-5","article-title":"Vasopressin regulates rat mesangial cell growth by inducing autocrine secretion of vascular endothelial growth factor","volume":"61","author":"Tahara","year":"2011","journal-title":"J Physiol Sci"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib113","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.pathol.4.110807.092150","article-title":"A glimpse of various pathogenetic mechanisms of diabetic nephropathy","volume":"6","author":"Kanwar","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib114","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.febslet.2011.01.004","article-title":"CTGF\/CCN2 activates canonical Wnt signalling in mesangial cells through LRP6: implications for the pathogenesis of diabetic nephropathy","volume":"585","author":"Rooney","year":"2011","journal-title":"FEBS Lett"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib115","doi-asserted-by":"crossref","first-page":"40725","DOI":"10.1074\/jbc.M006509200","article-title":"Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells","volume":"275","author":"Suzuma","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib116","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1096\/fj.01-0332fje","article-title":"Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis","volume":"16","author":"Inoki","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib117","doi-asserted-by":"crossref","first-page":"36288","DOI":"10.1074\/jbc.M201674200","article-title":"Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165","volume":"277","author":"Hashimoto","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib118","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1523-1755.2002.00462.x","article-title":"Nitric oxide down-regulates connective tissue growth factor in rat mesangial cells","volume":"62","author":"Keil","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib119","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.2353\/ajpath.2009.080792","article-title":"Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease","volume":"175","author":"Hakroush","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib120","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cmet.2010.08.015","article-title":"Insulin signaling to the glomerular podocyte is critical for normal kidney function","volume":"12","author":"Welsh","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.semnephrol.2012.06.010_bib121","doi-asserted-by":"crossref","first-page":"F99","DOI":"10.1152\/ajprenal.00466.2009","article-title":"Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis.s","volume":"299","author":"Wang","year":"2010","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929512000885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929512000885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T05:49:32Z","timestamp":1643348972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929512000885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":120,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0270929512000885"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2012.06.010","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}